RAN 2013 Conference: Clinical Trials in the Era of Genomic Medicine

Input from advocates during the design phase has made a difference in the outcomes of cancer clinical trials. Advocates are key stakeholders in clinical trials and are being asked to be involved in the design of clinical trials at earlier stages but need to be prepared and trained for this involvement. On November 20‐22, 2013, Research Advocacy Network hosted a symposium for advocates to address this need for earlier advocate input.

Read More